Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Cord Clamping Among Neonates With Congenital Heart Disease
NCT06153459 · View on ClinicalTrials.gov ↗
Study Summary
The goal of this clinical trial is to compare 2 different timepoints for clamping the umbilical cord at birth for term-born infants with a prenatal diagnosis of congenital heart disease (CHD). The main questions it aims to answer are: * Does Delayed Cord Clamping at 120 seconds (DCC-120) or Delayed Cord Clamping at 30 seconds (DCC-30) after birth lead to better health outcomes? * Does DCC-120 seconds or DCC-30 seconds after birth lead to better neuromotor outcomes at 22-26 months of infant age (postnatal)? Participants will be asked to do the following: * Participate in either DCC-120 or DCC-30 at birth (randomized assignment). * Complete General Movements Assessment (GMA) at 3-4 months of infant age (postnatal), complete questionnaires / surveys at this time. * Complete questionnaires / surveys at 9-12 months of infant age (postnatal). * Complete Hammersmith Infant Neurological Examination (HINE), Developmental Assessment of Young Children 2 Edition (DAYC-2), and questionnaires / surveys at 22-26 months of infant age (postnatal). * Permit data collection from electronic medical records for both the mother and infant study participants. Investigators will compare DCC-120 vs. DCC-30 to see which approach is more beneficial to both the mother and baby with CHD.
Conditions Studied
Interventions
- PROCEDURE Umbilical Cord Clamping at ~30 seconds
- PROCEDURE Umbilical Cord Clamping at ~120 seconds
- PROCEDURE Umbilical Cord Milking
Study Locations (20)
California
- Cedars-Sinai Medical Center — Los Angeles
- Children's Hospital of Orange County — Orange
- Lucile Packard Children's Hospital Stanford — Palo Alto
- Sharp Mary Birch Hospital for Woman and Newborns — San Diego
Missouri
- The Children's Mercy Hospital — Kansas City
- SSM Health Cardinal Glennon Children's Hospital — St Louis
Texas
- Texas Children's Hospital — Houston
- University of Texas Health Science Center at San Antonio — San Antonio
Alabama
- Children's of Alabama — Birmingham
Florida
- UF Health Shands Children's Hospital — Gainesville
Maryland
- Johns Hopkins Children's Center — Baltimore
Mississippi
- Children's of Mississippi — Jackson
North Carolina
- Duke Children's Hospital & Health Center — Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-12-19 |
| Est. Completion | 2030-12 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06153459
The ClinicalTrials.gov registry entry for NCT06153459 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carl Backes, MD, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Congenital Heart Disease (CHD) appearing as the primary indexed condition, and to 3 interventions — of which Umbilical Cord Clamping at ~30 seconds is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT06153459 reports 20 study locations spanning 15 distinct geographic areas — top geographies include California, Missouri, Texas. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT06153459 about?
NCT06153459 is a clinical study titled "Cord Clamping Among Neonates With Congenital Heart Disease". The goal of this clinical trial is to compare 2 different timepoints for clamping the umbilical cord at birth for term-born infants with a prenatal diagnosis of congenital heart disease (CHD). The main questions it aims to answer are: * Does Delayed Cord Clamping at 120 seconds (DCC-120) or Delayed...
What is the current status of trial NCT06153459?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2023-12-19. Estimated completion is 2030-12.
What conditions does trial NCT06153459 study?
This clinical trial studies the following conditions: Congenital Heart Disease (CHD). These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT06153459?
The interventions under investigation include: Umbilical Cord Clamping at ~30 seconds (PROCEDURE), Umbilical Cord Clamping at ~120 seconds (PROCEDURE), Umbilical Cord Milking (PROCEDURE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT06153459?
This trial is sponsored by Carl Backes, MD, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT06153459 being conducted?
This trial has 20 study locations across Alabama, California, Florida, Maryland, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.